BioCardia Warrants
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BCDAW and buy or sell other stocks, ETFs, and their options commission-free!About BCDAW
BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and Avance Steerable Introducers.
CEOPeter Alan Altman, PhD
CEOPeter Alan Altman, PhD
Employees—
Employees—
HeadquartersSunnyvale, California
HeadquartersSunnyvale, California
Founded1994
Founded1994
Employees—
Employees—
BCDAW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume13.23K
Average volume13.23K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.90
52 Week high$0.90
52 Week low$0.0059
52 Week low$0.0059
Stock Snapshot
The current BioCardia Warrants(BCDAW) stock price is $0.01.
BioCardia Warrants(BCDAW) stock opened on 2025-12-24 at —. The price climbed to — and dipped to —.
BioCardia Warrants(BCDAW) shares are trading with a volume of 0, against a daily average of 13.23K.
In the last year, BioCardia Warrants(BCDAW) shares hit a 52-week high of $0.90 and a 52-week low of $0.01.
In the last year, BioCardia Warrants(BCDAW) shares hit a 52-week high of $0.90 and a 52-week low of $0.01.